Stock AUTL AUTOLUS THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Autolus Therapeutics plc

Equities

AUTL

US05280R1005

Real-time Estimate Cboe BZX
Other stock markets
 02:49:23 2024-04-29 pm EDT 		5-day change 1st Jan Change
3.945 USD -1.38% Intraday chart for Autolus Therapeutics plc -13.49% -38.74%
Apr. 25 European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT
Apr. 19 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
MT
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
MT
European Equities Close Lower Tuesday; Eurozone Manufacturing at 3-Month Low; Mining Stocks Rally, Real Estate Drops
MT
Autolus Therapeutics Gets European Agency Approval for Marketing Authorization Application for Leukemia Treatment
MT
Autolus Therapeutics Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)
CI
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises
AN
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher
MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday
MT
Syncona portfolio company Autolus posts widened loss for 2023
AN
Autolus Therapeutics 2023 Net Loss Narrows, Revenue Falls
MT
Autolus Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Autolus Therapeutics Receives Manufacturing Authorization, Two New Licenses for Nucleus Facility
MT
BioNTech, Autolus to Advance CAR-T Cell Therapy Programs; Autolus Prices $350 Million Offering
MT
BioNTech Signs License, Investment Deals With Autolus Therapeutics
MT
BioNTech Agrees To Invest $200 Million in Autolus, Starts Strategic Collaboration
DJ
BioNTech SE and Autolus Therapeutics plc Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AUTL Stock
  4. News Autolus Therapeutics plc
  5. Highlights